Table 4: Relationship between clinical parameters and histopathological response to NRCT (n = 109).
|
|
Clinical factor |
Case no (n = 109) |
Good response (n = 52) |
Poor response (n = 57) |
P |
|
Age (years) |
≤ 60 |
60 (55%) |
30 (27.5%) |
30 (27.5%) |
0.596 |
|
> 60 |
49 (45%) |
22 (20%) |
27 (25%) |
||
|
Sex |
Male |
55 (50%) |
28 (26%) |
27 (25%) |
0.499 |
|
Female |
54 (50%) |
24 (22%) |
30 (27%) |
||
|
Clinical T stage* |
cT2 |
4 (4%) |
4 (4%) |
0 (0%) |
0.068 |
|
cT3 |
93 (85%) |
44 (40%) |
49 (45%) |
||
|
cT4 |
12 (11%) |
4 (4%) |
8 (7%) |
||
|
Clinical N stage |
cN0 |
41 (%) |
18 (17%) |
23 (21%) |
0.537 |
|
cN1-2 |
68 (%) |
34 (31%) |
34 (31%) |
||
|
Distance from AV (cm) |
< 5 |
34 (31%) |
14 (13%) |
20 (18%) |
0.384 |
|
5-10 |
43 (39%) |
24 (22%) |
19 (17%) |
||
|
> 10 |
32 (30%) |
14 (13%) |
18 (17%) |
||
|
Time to surgery (weeks) |
≤ 7 |
64 (59%) |
23 (21%) |
41 (38%) |
0.003 |
|
> 7 |
45 (41%) |
29 (27%) |
16 (14%) |
*2 cells (33.3%) have expected count less than 5
Statistical analysis with chi-square test, level of significance P < 0.05